Skip to content
OpenCapital
Get started

Halozyme Therapeutics HALO Interest coverage

Interest coverage at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
114.2×+46.4×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-7.1×-0.8×
Arrowhead Research logo
Arrowhead ResearchARWR
-2.4×+0.9×
LQD
Liquidia CorporationLQDA
-4.9×-1.6×
AptarGroup logo
AptarGroupATR
8.5×-2.6×
Alkermes logo
AlkermesALKS
5.8×-17.8×

Other financials

Income statement

See full
Revenue$376.7M+42.2%
Gross profit$297.5M+37.4%
Operating income$184.5M+30.4%
Net income$150.0M+27.1%
EPS (diluted)$1.22+31.2%

Balance sheet

See full
Cash & equivalents$312.0M+76.9%
Total debt$2.2B+41.7%
Total equity$219.6M-54.5%
Total assets$2.7B+21.7%

Cash flow

See full
Operating cash flow$180.1M+16.8%
CapEx$3.7M+294%
Free cash flow$176.3M+15.0%

Valuation

See full
Market cap$8.13B-2.9%
Enterprise value$10B+3.0%
P/E13.4×-3.8×
P/S5.4×-2.3×

Profitability

See full
Gross margin82.8%-0.7pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin44.3%-1.5pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity9.9×+6.7×
Current ratio2.8×-5.6×

Where this comes from

Calculated from Halozyme Therapeutics’s reported figures.

ebit/interest expense=41.5×

Based on trailing twelve months.

The official record: Halozyme Therapeutics’s 10-Q, filed November 3, 2025, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Halozyme Therapeutics's interest coverage?
Halozyme Therapeutics (HALO) reported interest coverage of 41.5× in Q3 2025.
How has Halozyme Therapeutics's interest coverage changed year-over-year?
Halozyme Therapeutics's interest coverage increased by 63.5% year-over-year, from 25.4× to 41.5×.
What is the long-term trend for Halozyme Therapeutics's interest coverage?
Over 4 years (2020 to 2024), Halozyme Therapeutics's interest coverage has grown at a 44.0% compound annual growth rate (CAGR), from 7.1× to 30.5×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.